GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (WBO:PHM) » Definitions » Dividend Payout Ratio

Pharma Mar (WBO:PHM) Dividend Payout Ratio : 0.00 (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Pharma Mar Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Pharma Mar's Dividend Payout Ratio for the months ended in Sep. 2024 was 0.00.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Pharma Mar SA is 27.08, which seems too high.

The historical rank and industry rank for Pharma Mar's Dividend Payout Ratio or its related term are showing as below:

WBO:PHM' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.06   Med: 0.17   Max: 27.08
Current: 27.08


During the past 13 years, the highest Dividend Payout Ratio of Pharma Mar was 27.08. The lowest was 0.06. And the median was 0.17.

WBO:PHM's Dividend Payout Ratio is ranked worse than
99.29% of 140 companies
in the Biotechnology industry
Industry Median: 0.48 vs WBO:PHM: 27.08

As of today (2024-12-13), the Dividend Yield % of Pharma Mar is 0.83%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Pharma Mar was 4.32%. The lowest was 0.36%. And the median was 1.06%.

Pharma Mar's Dividends per Share for the months ended in Sep. 2024 was €0.00.

During the past 3 years, the average Dividends Per Share Growth Rate was 10.60% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Pharma Mar was 10.60% per year. The lowest was 10.60% per year. And the median was 10.60% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Pharma Mar Dividend Payout Ratio Historical Data

The historical data trend for Pharma Mar's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar Dividend Payout Ratio Chart

Pharma Mar Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 16.25

Pharma Mar Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 10.32 -

Competitive Comparison of Pharma Mar's Dividend Payout Ratio

For the Biotechnology subindustry, Pharma Mar's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Mar's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Mar's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Pharma Mar's Dividend Payout Ratio falls into.



Pharma Mar Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Pharma Mar's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2023 )/ EPS without NRI (A: Dec. 2023 )
=0.65/ 0.04
=16.25

Pharma Mar's Dividend Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Sep. 2024 )/ EPS without NRI (Q: Sep. 2024 )
=0/ 0.224
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharma Mar (WBO:PHM) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Pharma Mar Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Pharma Mar's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Mar Business Description

Traded in Other Exchanges
Address
Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.